Thursday, December 6, 2012

• 4 Biotechs With Poor Balance Sheetsat Seeking Alpha (Thu, Dec 6)

Friday, November 30, 2012

• Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Coveringat Seeking Alpha (Fri, Nov 30)

Thursday, November 29, 2012

• NVS Discusses Data Readout PlansZacks (Thu, Nov 29)

Wednesday, November 28, 2012

• Best Biotechnology and Pharmaceutical Investing Interviews of 2012: New Oncology Treatments in Rapid Development as Explained by Expert AnalystWall Street Transcript (Wed, Nov 28)
• Incyte to Present at the Oppenheimer 23rd Annual Healthcare ConferenceBusiness Wire (Wed, Nov 28)

Wednesday, November 21, 2012

• The Zacks Analyst Blog Highlights: Incyte, Eli Lilly, Johnson & Johnson, Abbott Laboratories and Express Scripts HoldingZacks (Wed, Nov 21)

Tuesday, November 20, 2012

• Incyte Progresses on RA CandidateZacks (Tue, Nov 20)

Monday, November 19, 2012

• Incyte to Present at the 24th Annual Piper Jaffray Healthcare ConferenceBusiness Wire (Mon, Nov 19)

Thursday, November 15, 2012

• INCYTE CORP Files SEC form 8-K, Other EventsEDGAR Online (Thu, Nov 15)
• Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid ArthritisBusiness Wire (Thu, Nov 15)

Wednesday, November 14, 2012

• Nokia Retains Neutral and 3 Stock Analyses to Eyeat Wall St. Cheat Sheet (Wed, Nov 14)
• Incyte price target raised to $29 from $25 at RW Bairdtheflyonthewall.com (Wed, Nov 14)

Monday, November 12, 2012

• ASH 2012 Preview: Top Picks For Upcoming Blood Cancer Meetingat Seeking Alpha (Mon, Nov 12)

Sunday, November 11, 2012

• Medical Advances May Help Improve Psoriasis Outcomesat Seeking Alpha (Sun, Nov 11)

Wednesday, November 7, 2012

• A Blockbuster in the Makingat Motley Fool (Wed, Nov 7)
• Can Pfizer's New Drug Clip Abbott's Top-Selling Humira?at Minyanville (Wed, Nov 7)

Tuesday, November 6, 2012

• Incyte Narrows LossZacks (Tue, Nov 6)
• Bloomberg Reporter Gets Second Opinion on DNA Testat Bloomberg (Tue, Nov 6)
• My DNA Results Spur Alzheimer’s Anxiety at $12,000 Costat Bloomberg (Tue, Nov 6)

Monday, November 5, 2012

• Incyte to Present at the Jefferies 2012 Global Healthcare Conference (London)Business Wire (Mon, Nov 5)

Thursday, November 1, 2012

• Why Incyte Shares Roared Higherat Motley Fool (Thu, Nov 1)
• Incyte's CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Nov 1)
• INCYTE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Nov 1)

Wednesday, October 31, 2012

• Biotech Earnings Preview: Vertex, Dendreon, Incyte, Medivation, Onyx (Updated)at TheStreet (Wed, Oct 31)

Monday, October 29, 2012

• Biotech Earnings Preview: Vertex, Onyx, Dendreon, Medivationat TheStreet (Mon, Oct 29)

Add INCY News to My Yahoo!